Dec. 23, 2021
Companies Produce 'Tens of Millions' More Rapid COVID Tests
By info@inbios.com|2023-10-25T19:48:32+00:00January 3rd, 2022|InBios In the News|
Companies Produce 'Tens of Millions' More Rapid COVID Tests
By info@inbios.com|2023-10-25T19:48:50+00:00January 3rd, 2022|InBios In the News|
U.S. Testing Struggles to Keep Up with Omicron
By info@inbios.com|2023-10-25T19:49:08+00:00January 3rd, 2022|InBios In the News|
InBios Receives FDA EUA for Home Use Antigen Test for COVID-19
By info@inbios.com|2023-10-25T19:49:54+00:00November 1st, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
By info@inbios.com|2023-10-25T19:52:03+00:00October 4th, 2021|Conferences|
AACC Annual Meeting, Sept. 26-30, Atlanta, GA
By info@inbios.com|2023-10-25T19:52:25+00:00October 4th, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 IgG Antibody Rapid Test
By info@inbios.com|2023-10-25T19:52:42+00:00October 4th, 2021|InBios In the News|
New Studies Suggest InBios COVID-19 POC Antigen Test Will Detect Delta Variant
By info@inbios.com|2023-10-25T19:53:12+00:00October 4th, 2021|InBios In the News|
Curebase, InBios Announce Results of Virtual Clinical Trial
By info@inbios.com|2023-10-25T19:53:30+00:00May 12th, 2021|InBios In the News|
InBios Receives FDA EUA for COVID-19 POC Antigen Detection Test
By info@inbios.com|2023-10-25T19:53:47+00:00November 9th, 2020|InBios In the News|
InBios Awarded Contract Through US Army for SCoV-2 Infection Clinical Trials